APA (7th ed.) Citation

Singata-Madliki, M., Smit, J., Beksinska, M., Balakrishna, Y., Avenant, C., Beesham, I., . . . Hofmeyr, G. J. (2024). Effects of injectable contraception with depot medroxyprogesterone acetate or norethisterone enanthate on estradiol levels and menstrual, psychological and behavioral measures relevant to HIV risk: The WHICH randomized trial. PLoS ONE, 19(3), 1. https://doi.org/10.1371/journal.pone.0295764

Chicago Style (17th ed.) Citation

Singata-Madliki, Mandisa, et al. "Effects of Injectable Contraception with Depot Medroxyprogesterone Acetate or Norethisterone Enanthate on Estradiol Levels and Menstrual, Psychological and Behavioral Measures Relevant to HIV Risk: The WHICH Randomized Trial." PLoS ONE 19, no. 3 (2024): 1. https://doi.org/10.1371/journal.pone.0295764.

MLA (9th ed.) Citation

Singata-Madliki, Mandisa, et al. "Effects of Injectable Contraception with Depot Medroxyprogesterone Acetate or Norethisterone Enanthate on Estradiol Levels and Menstrual, Psychological and Behavioral Measures Relevant to HIV Risk: The WHICH Randomized Trial." PLoS ONE, vol. 19, no. 3, 2024, p. 1, https://doi.org/10.1371/journal.pone.0295764.